Sites
Notifications
Saved Sites
| Linked studies | Actions | ||||||
|---|---|---|---|---|---|---|---|
| Active partner | NHS | NIHR RDN | Oncology+1 | BRCA · Fea/Ast/01+9 | London | ||
| Active partner | NHS | — | Oncology+3 | T2D · Fea/Boe/01+4 | Cambridge | ||
| Active partner | NHS | NIHR RDN | Oncology+3 | BRCA · Fea/Ast/01+9 | London | ||
| Active partner | NHS | Parexel Site Alliance | Oncology+3 | COPD · Fea/San/01+7 | London | ||
| Active partner | NHS | NIHR RDN | Oncology+2 | BRCA · Fea/Ast/01+4 | London | ||
| Active partner | NHS | NIHR RDN | Respiratory | BRCA · Fea/Ast/01+3 | Leeds | ||
| Active partner | NHS | Parexel Site Alliance | Metabolic | T2D · Fea/Boe/01+2 | Liverpool | ||
| Active partner | NHS | NIHR RDN | Oncology+4 | BRCA · Fea/Ast/01+7 | Manchester | ||
| Pending agreement | NHS | — | Rheumatology | — | Glasgow | ||
| Active partner | NHS | NIHR RDN | Neurology | COPD · Fea/San/01+3 | Edinburgh | ||
| Active partner | NHS | FutureMeds | Cardiovascular | COPD · Fea/San/01+2 | Bristol | ||
| Active partner | NHS | WCG Site Network | Metabolic | T2D · Fea/Boe/01+2 | Nottingham | ||
| Active partner | NHS | Accellacare | Oncology | BRCA · Fea/Ast/01+1 | Oxford | ||
| Active partner | NHS | IQVIA Prime Site | Oncology+2 | BRCA · Fea/Ast/01+1 | London | ||
| Active partner | NHS | NIHR RDN | Neurology | COPD · Fea/San/01+7 | Sheffield | ||
| Pending agreement | NHS | NIHR RDN | Oncology+1 | — | London | ||
| Active partner | NHS | IQVIA Prime Site | Cardiovascular | BRCA · Fea/Ast/01+4 | Newcastle upon Tyne | ||
| Active partner | NHS | Accellacare | Oncology+1 | BRCA · Fea/Ast/01+1 | London | ||
| Active partner | NHS | WCG Site Network | Oncology+4 | BRCA · Fea/Ast/01+7 | London | ||
| Active partner | NHS | NIHR RDN | Neurology | COPD · Fea/San/01+7 | Birmingham |
sites = 20